Clinical Trials Directory

Trials / Completed

CompletedNCT02813538

Major Liver Resection: Early Clotting Disorders and Functional Impairment.

Hypercoagulability and Liver Function After Major Liver Resection

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Hospital General Universitario Gregorio Marañon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate early clotting disorders through thromboelastogram and anticoagulant proteins levels (maybe also endothelial markers) and liver function by indocyanine green clearance after major liver resection and search for a potential relationship between them.

Detailed description

We are prospectively recording data from patients undergoing major liver resection. We obtain a full procoagulant and anticoagulant profile preoperatively and, at first, second and sixth day after surgery. We also measure indocyanine green (ICG) clearance preoperatively and in the first two postoperative days. We are also recording clinical data, focusing on medical and surgical complications. We aim to establish the potential value of ICG clearance and or coagulation profile to predict clinical complications

Conditions

Interventions

TypeNameDescription
DRUGIndocyanine green clearanceTo evaluate liver function by injection of indocyanine green by a peripheral vein and measure its clearance
OTHERThromboelastometryTo evaluate blood coagulation impairment by obtaining blood sample from a peripheral vein and measure anticoagulant proteins levels plus obtaining thromboelastometry

Timeline

Start date
2016-02-05
Primary completion
2018-10-01
Completion
2019-04-01
First posted
2016-06-27
Last updated
2020-05-21

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02813538. Inclusion in this directory is not an endorsement.

Major Liver Resection: Early Clotting Disorders and Functional Impairment. (NCT02813538) · Clinical Trials Directory